简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-02-27 14:38 Galderma’s Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years
2026-02-26 10:33 Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics
2026-02-25 16:58 Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
2026-02-25 15:49 AOP Health on Rare Diseases: Information. Collaboration. Innovation.
2026-02-25 09:38 YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency
2026-02-25 09:19 Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis
2026-02-24 11:12 New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday
2026-02-24 10:56 Galderma Announces Appointment of New Chief Financial Officer
2026-02-12 18:38 We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties
2026-02-11 14:12 Galderma Expands Restylane® Portfolio in Japan With Launch of OBT™ Hyaluronic Acid Injectables Restylane Defyne™ and Refyne™
2026-02-11 10:55 Kirin and Immunosens Launch Joint Development of a Self-Testing Service That Uses Urinary IgA to Visualize a Person’s Immune Status
2026-02-10 16:30 U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
2026-02-09 11:42 Rapid Medical™’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke
2026-02-06 14:34 Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide
2026-02-05 18:25 Menicon’s Largest Malaysia Plant Begins Commercial Production
2026-02-05 18:14 Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
2026-02-05 13:37 China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA®
2026-02-03 13:44 Tastepoint by IFF Predicts Ten Flavor Trends for 2026
2026-02-03 10:50 Ensem Therapeutics Doses First Patient in China in ETX-636 Global Phase 1/2 Study
2026-02-02 17:03 Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission

Business Wire Weibo

Press Releases

Latest Releases